Compare CMND & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMND | DRCT |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.3M |
| IPO Year | 2021 | 2021 |
| Metric | CMND | DRCT |
|---|---|---|
| Price | $2.98 | $2.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 2.5M | 33.7K |
| Earning Date | 03-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,694,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $9.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.04 |
| 52 Week High | $4.66 | $7.21 |
| Indicator | CMND | DRCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 45.14 |
| Support Level | $0.31 | $2.73 |
| Resistance Level | $3.25 | $2.98 |
| Average True Range (ATR) | 0.44 | 0.21 |
| MACD | -0.10 | -0.05 |
| Stochastic Oscillator | 11.67 | 13.14 |
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.